BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Who knew? Future of medical esearch lies in online gaming

Oct. 11, 2010
By Omar Ford

Survey shows hospitals still waiting for reform changes

Oct. 7, 2010
By Omar Ford

LifeCell has favorable results from Strattice clinical study

Oct. 6, 2010
By Omar Ford
LifeCell (Branchburg, New Jersey), a subsidiary of Kinetic Concepts (KCI; San Antonio) reported that the LifeCell Strattice reconstructive tissue matrix achieved highly favorable one-year outcomes in an ongoing clinical study of single-stage repair of contaminated or infected ventral incisional hernias. (Medical Device Daily)
Read More

NovaBone gains approval for MIS delivery system

Oct. 5, 2010
By Omar Ford
Founded in 2002, with a direct staff of less than 20, NovaBone Products (Jacksonville, Florida) is seeking to gain a deeper foothold in the orthopedics market – proving itself to be the little med-tech company that could. The firm joins a host of companies hoping to break news on their innovations just in time for the North American Spine Society (NASS; Burr Ridge, Illinois) annual meeting being held this week in Orlando, Florida. (Medical Device Daily)
Read More

K2M in plan to launch Vikos Allograft System

Oct. 4, 2010
By Omar Ford
K2M (Leesburg, Virginia) is hoping to make its mark in the spinal biologics market with the launch of its Vikos Cervical Allograft System. The company teamed up with LifeNet Health (Virginia Beach, Virginia), an allograft bio-implant and regenerative medicine company, to combine quality machined allograft implants with precision instrumentation. (Medical Device Daily)
Read More

Tryton releases interim data for branch stent system

Oct. 1, 2010
By Omar Ford

Researchers build 'bioreactor' to help treat hydrocephalus

Sep. 30, 2010
By Omar Ford

Deals roundup: Crocker Ventures acquires TMJ Implants for undisclosed sum

Sep. 30, 2010
By Omar Ford

St. Jude moves forward with TAVI clinical trial

Sep. 29, 2010
By Omar Ford
St. Jude Medical (St. Paul, Minnesota) could be on the verge of launching its transcatheter aortic valve implantation clinical trial (TAVI) soon. The trial will evaluate the safety and efficacy of the company's transcatheter aortic valve for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery. (Medical Device Daily)
Read More

New ventures: Ib2c launches with product aimed at increasing fertility

Sep. 27, 2010
By Omar Ford
Previous 1 2 … 167 168 169 170 171 172 173 174 175 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 16, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Medical illustration showing layers of a blood vessel

    Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis

    BioWorld Science
    More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
  • Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

    BioWorld Science
    Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing